Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
9.70
+0.60 (6.59%)
At close: Oct 24, 2025, 4:00 PM EDT
9.89
+0.19 (1.96%)
Pre-market: Oct 27, 2025, 7:40 AM EDT

Kura Oncology Stock Forecast

Stock Price Forecast

The 10 analysts that cover Kura Oncology stock have a consensus rating of "Strong Buy" and an average price target of $25, which forecasts a 157.73% increase in the stock price over the next year. The lowest target is $10 and the highest is $40.

Price Target: $25 (+157.73%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$10$25$28$40
Change+3.09%+157.73%+188.66%+312.37%

Analyst Ratings

The average analyst rating for Kura Oncology stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingMay '25Jun '25Jul '25Aug '25Sep '25Oct '25
Strong Buy555555
Buy555666
Hold222232
Sell000000
Strong Sell000000
Total121212131413

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
JMP Securities
JMP Securities
Buy
Reiterates
$24
BuyReiterates$24+147.42%Oct 20, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$40
Strong BuyReiterates$40+312.37%Oct 20, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$40
Strong BuyReiterates$40+312.37%Sep 30, 2025
Guggenheim
Guggenheim
Hold
Initiates
n/a
HoldInitiatesn/an/aSep 4, 2025
JMP Securities
JMP Securities
Buy
Maintains
$28$24
BuyMaintains$28$24+147.42%Aug 11, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
90.86M
from 53.88M
Increased by 68.63%
Revenue Next Year
219.52M
from 90.86M
Increased by 141.59%
EPS This Year
-2.55
from -2.02
EPS Next Year
-2.63
from -2.55
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
----53.88M90.86M219.52M
Revenue Growth
-----68.63%141.59%
EPS
-1.69-1.97-2.03-2.08-2.02-2.55-2.63
EPS Growth
-------
Forward PE
-------
No. Analysts
-----1615
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High171.2M473.8M
Avg90.9M219.5M
Low28.8M31.1M

Revenue Growth

Revenue Growth20252026202720282029
High
217.6%
421.4%
Avg
68.6%
141.6%
Low
-46.5%
-65.8%

EPS Forecast

EPS20252026202720282029
High-1.65-1.03
Avg-2.55-2.63
Low-3.32-4.83

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.